(Q34470423)

2 August 2017

title

Rational design of low-molecular weight heparins with improved in vivo activity (English)

1 reference

2 August 2017

0 references

Robert S. Langer, Jr.

7

object named as

Robert Langer

1 reference

2 August 2017

8

Ram Sasisekharan

1 reference

2 August 2017

3

Zachary Shriver

1 reference

2 August 2017

5

Ganlin Zhao

1 reference

2 August 2017

Mallik Sundaram

1

1 reference

2 August 2017

Yiwei Qi

2

1 reference

2 August 2017

Dongfang Liu

4

1 reference

2 August 2017

Ganesh Venkataraman

6

1 reference

2 August 2017

language of work or name

English

0 references

publication date

13 January 2003

1 reference

Proceedings of the National Academy of Sciences of the United States of America

2 August 2017

published in

1 reference

2 August 2017

volume

100

1 reference

2 August 2017

issue

2

1 reference

2 August 2017

page(s)

651-656

1 reference

RNA aptamers as reversible antagonists of coagulation factor IXa.

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=141051

Heparin-induced thrombocytopenia: temporal pattern of thrombocytopenia in relation to initial use or reexposure to heparin

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=141051

Heparin-induced thrombocytopenia: pathophysiology and management

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=141051

How we diagnose and treat deep vein thrombosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=141051

Tissue factor pathway inhibitor: an update of potential implications in the treatment of cardiovascular disorders

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=141051

Comparative pharmacokinetics of LMWHs

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=141051

Cleavage of the antithrombin III binding site in heparin by heparinases and its implication in the generation of low molecular weight heparin

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=141051

Sequencing of 3-O sulfate containing heparin decasaccharides with a partial antithrombin III binding site

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=141051

Low molecular weight heparins in the prevention of deep-vein thrombosis in general surgery.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=141051

Structural characterization of low molecular weight heparins

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=141051

Sequencing complex polysaccharides

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=141051

The anticoagulant activation of antithrombin by heparin

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=141051

Absolute molecular weight distribution of low-molecular-weight heparins by size-exclusion chromatography with multiangle laser light scattering detection

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=141051

Expression in Escherichia coli, purification and characterization of heparinase I from Flavobacterium heparinum

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=141051

Enzymatic degradation of glycosaminoglycans

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=141051

The role of hypercoagulability in venous and arterial thrombosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=141051

Experimental studies on venous thrombosis: effect of coagulants, procoagulants and vessel contusion.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=141051

Comparative study on the in vitro and in vivo activities of seven low-molecular-weight heparins

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=141051

In vitro protamine neutralization profiles of heparins differing in source and molecular weight

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=141051

Rat model of arterial thrombosis induced by ferric chloride

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=141051

Low molecular weight heparins: an introduction

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=141051

Disaccharide compositional analysis of heparin and heparan sulfate using capillary zone electrophoresis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=141051

Poor reversal of low molecular weight heparin by protamine

6 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1073%2FPNAS.252643299

Differential effect of unfractionated heparin and low molecular weight heparin on intravascular tissue factor pathway inhibitor: evidence for a difference in antithrombotic action

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1073%2FPNAS.252643299

Dose-dependent release of endogenous tissue factor pathway inhibitor by different low molecular weight heparins

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1073%2FPNAS.252643299

Histidine 295 and histidine 510 are crucial for the enzymatic degradation of heparan sulfate by heparinase III

21 January 2018

1 reference

12 December 2020

Endogenous tissue factor pathway inhibitor modulates thrombus formation in an in vivo model of rabbit carotid artery stenosis and endothelial injury

1 reference

12 December 2020

Heparin induces synthesis and secretion of tissue factor pathway inhibitor from endothelial cells in vitro

1 reference

12 December 2020

Experimental Proof for the Structure of a Thrombin-Inhibiting Heparin Molecule

1 reference

12 December 2020

Assay of heparin in plasma using a chromogenic substrate for activated factor X

1 reference

12 December 2020

Evaluation of an amidolytic heparin assay method: increased sensitivity by adding purified antithrombin III

1 reference

12 December 2020

Neutralization of enoxaparine-induced bleeding by protamine sulfate

1 reference

12 December 2020

The extrinsic pathway inhibitor: a regulator of tissue factor-dependent blood coagulation

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of a low molecular weight heparin (enoxaparin) after subcutaneous injection, comparison with unfractionated heparin--a three way cross over study in human volunteers

1 reference

12 December 2020

Synthesis and comparison of tripeptidylfluoroalkane thrombin inhibitors

1 reference

12 December 2020

Identifiers

DOI

10.1073/PNAS.252643299

1 reference

2 August 2017

0 references

1 reference

2 August 2017

1 reference